Novo Nordisk

Wire2d ago

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

Novo Nordisk (NVO) shares fell 2.5% in Friday trading after Morgan Stanley downgraded the stock to underweight from equal weight.Intraday volume topped 7.92 million shares, compared with the daily average of 11.5 million.Price: $42.93, Change: $-1.09, Percent Change: -2.47%

$AKTX$AUTL$BBVA$BDRX$CLLS$DAVA$DBVT$E$FOCL$MREO$NOK$NVO$SAN$SLN$TRIB$WPP

Asia Markets2d ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.53% to 1,939.78 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which were up 3.1% and 1.8% respectively. They were followed by medical device maker EDAP TMS (FOCL) and lender Banco Santander (SAN), which increased 1.7% and 1.4% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Novo Nordisk (NVO), which dropped 3.5% and 2.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and oil and gas company Eni (E), which lost 1.5% and 1.3% respectively.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Mereo BioPharma Group (MREO), which surged 86% and 13% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which advanced 2.7% and 1.8% respectively.The decliners from the UK and Ireland were led by biotech firms Trinity Biotech (TRIB) and Autolus Therapeutics (AUTL), which fell 12% and 4.1% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and communications company WPP (WPP), which were down 1.1% and 1% respectively.

Research2d ago

Morgan Stanley Downgrades Novo Nordisk to Underweight From Equalweight, Price Target is $40

Novo Nordisk A/S (NVO) has an average rating of hold and mean price target of $44.50, according to analysts polled by FactSet.

Dow JonesNasdaq CompositeS&P 500$ASML$BSX$LMT$NVO$NVS$ROIV$TSM

Sectors5d ago

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks declined late Tuesday afternoon with the NYSE Healthcare Index falling 2.5% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 2.2%.The iShares Biotechnology ETF (IBB) shed 1.9%.In corporate news, Boston Scientific (BSX) flagged its inability to meet its near-term financial outlooks amid a "material impact" from a recent cybersecurity incident. Boston Scientific shares were down 5%.Novartis (NVS) shares fell past 13% after it said a phase 3 trial assessing delpacibart etedesiran in people with myotonic dystrophy type 1 failed to meet its primary endpoint.GSK (GSK) is raising $6.5 billion from a US high-grade debt sale to help refinance bridge funding for its $10.6 billion takeover of Nuvalent, Bloomberg reported. GSK shares fell 2.4%.Novo Nordisk (NVO) has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study, Reuters reported. The trials, which tested the drug in heart failure patients, will end early, the company told. It added that patients will continue through to their 3-months follow-up as already planned. Novo shares were shedding 2.7%.

$BSX$GSK$NVO$NVS

Sectors5d ago

Sector Update: Healthcare Stocks Fall Tuesday Afternoon

Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index falling 2.4% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 2.2%.The iShares Biotechnology ETF (IBB) shed 1.8%.In corporate news, Novartis (NVS) shares fell past 13% after it said a phase 3 trial assessing delpacibart etedesiran in people with myotonic dystrophy type 1 failed to meet its primary endpoint.Boston Scientific (BSX) identified a cybersecurity incident affecting some information technology systems that resulted in a global disruption of its operations. The company expects to recover part of the affected revenue but said it is unlikely to meet its net sales growth and adjusted EPS guidance ranges for Q3 and the full year. Boston Scientific shares were down 5.1%.Novo Nordisk (NVO) has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study, Reuters reported. The trials, which tested the drug in heart failure patients, will end early, the company told. It added that patients will continue through to their 3-months follow-up as already planned. Novo shares were shedding 2.7%.

$BSX$NVO$NVS

Asia Markets5d ago

Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock movements.)US equity futures were mostly lower pre-bell Tuesday, coming off a three-day weekend as traders assessed rising oil prices and Canada's retaliatory tariffs against the US.Dow Jones Industrial Average futures were 0.7% lower, S&P 500 futures were down 0.2%, and Nasdaq futures were 0.2% higher.Canadian tariffs, which were announced after trade talks with the US collapsed last month, took effect on Tuesday and range from 15% to 50%, impacting hundreds of US products, including dairy, agricultural equipment, paper, household appliances and electronics.US President Donald Trump, in a Monday post on Truth Social, called for a boycott of Canadian aerospace manufacturer Bombardier, saying "If they want our Market, they must build here, and stop treating America like a 'piggybank'". In response, the company told CNBC that its workers are based all over the US, with sites in 10 states, while its aircraft are constructed using US-made components.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 1.1% at $98.04 per barrel and US West Texas Intermediate crude 1.7% higher at $93.01 per barrel.The National Federation of Independent Business' monthly Small Business Optimism Index fell to a reading of 98.7 in August from 99.8 in July.In other world markets, Japan's Nikkei closed 1.7% lower, Hong Kong's Hang Seng ended 0.4% lower, and China's Shanghai Composite finished 0.2% higher. Meanwhile, the UK's FTSE 100 was flat, and Germany's DAX index was flat in Europe's early afternoon session.In equities, Taiwan Semiconductor Manufacturing (TSM) and ASML (ASML) shares rose 1.8% and 3.8%, respectively, after the two companies said they are collaborating on a project to move chipmaking to larger numerical aperture extreme ultraviolet masks. Lockheed Martin (LMT) stock was up 1.3% after UBS upgraded the company's stock to buy from neutral and adjusted the price target to $674 From $581. Roivant Sciences (ROIV) shares were more than 20% higher after the company said its Pulmovant unit's phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-ILD, met its primary and secondary endpoints.On the losing side, Novartis (NVS) stock dropped more than 12% after the company said its phase 3 Harbor study evaluating delpacibart etedesiran in patients with myotonic dystrophy type 1 failed to meet its primary endpoint of video hand opening time. Novo Nordisk (NVO) shares fell 1.8% after a Reuters report on Monday that the company has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study. Boston Scientific (BSX) stock was down 1.4% after the company said it is unlikely to meet its net sales growth and adjusted EPS guidance ranges for the third quarter and full year 2026 after identifying a cybersecurity incident that resulted in a global disruption to its operations.

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index falling 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.1%.The iShares Biotechnology ETF (IBB) was down 1%.In corporate news, Bristol Myers Squibb (BMY) told regulators, researchers and patient groups in early June that it had paused trials of its CAR-T treatment zola-cel in autoimmune disorders over potentially life-threatening side effects, The Wall Street Journal reported. Bristol Myers Squibb shares were falling 2%.Novo Nordisk's (NVO) charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Novo shares were down 2.2%.Immuron (IMRN) shares surged 57% after it said Friday it has signed an exclusive distribution agreement with Sweden's Calmino Group to launch PROIBS, a digestive-health medical device used for abdominal pain and bloating.Tarsus Pharmaceuticals (TARS) shares rose past 9% after the company said it has completed its acquisition of retinal disease-focused biotech Alkeus Pharmaceuticals.

$BMY$IMRN$NVO$TARS

$BNTX$BP$DBVT$E$EVAX$MREO$MTLS$NOK$NVO$SHEL$SNN$TRIB$TRVG$VOD

Sector Update: Healthcare Stocks Decline Friday Afternoon

Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.1%.The iShares Biotechnology ETF (IBB) was down 1%.In corporate news, Bristol Myers Squibb (BMY) told regulators, researchers and patient groups in early June that it had paused trials of its CAR-T treatment zola-cel in autoimmune disorders over potentially life-threatening side effects, The Wall Street Journal reported. Bristol Myers Squibb shares were falling 2.2%.Novo Nordisk's (NVO) charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Novo shares were down 2.1%.Intellia Therapeutics (NTLA) shares added 0.8% after it said Friday it entered a $400 million non-dilutive senior secured term loan facility with OrbiMed to support clinical and commercial milestones.Immuron (IMRN) shares surged 41% after the company announced Friday an exclusive distribution agreement for Probis in the US with Calmino.

$BMY$IMRN$NTLA$NVO

Asia Markets9d ago

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading

European equities traded in the US as American depositary receipts were marginally higher late Friday morning, rising 0.08% to 1,976.36 on the S&P Europe Select ADR Index, which was up about 0.9% for the week so far.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and 3D printer company Materialise (MTLS), which rose 2% and 1.6%, respectively. They were followed by biotech firm BioNTech (BNTX), which gained 0.8%.The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and oil and gas company Eni (E), which dropped 3.1% and 2.2%, respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company DBV Technologies (DBVT), which were down 2.1% and 1.7%, respectively.The gainers from the UK were led by telecommunications operator Vodafone Group (VOD) and oil and gas company Shell (SHEL), which advanced 2.2% and 0.9%, respectively. They were followed by oil and gas company BP (BP) and medical device maker Smith & Nephew (SNN), which were up 0.7% and 0.6%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Trinity Biotech (TRIB), which lost 4.5% and 3%, respectively. They were followed by software firm Endava (DAVA) and communications company WPP (WPP), which fell 2.6% and 2.2%, respectively.

Commodities9d ago

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday After August Jobs Report Tops Estimates

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.03%, and the actively traded Invesco QQQ Trust (QQQ) advanced 0.5% in Friday's premarket activity, as the August jobs report topped estimates.US stock futures were mixed, with S&P 500 Index futures down 0.24%, Dow Jones Industrial Average futures slipping 0.34%, and Nasdaq futures gaining 0.5% before the start of regular trading.Nonfarm payrolls jumped by 162,000, well above the 55,000 jobs increase expected in a survey compiled by Bloomberg as of 7:15 am ET.The unemployment rate remained at 4.1%, as expected, while the labor force participation rate rose to 61.6% from 61.4% in July and the size of the labor force surged.In premarket action, bitcoin was up by 1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 2.8% lower, Ether ETF (EETH) was down 2.91%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was down 0.38, the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was down 0.07, and the iShares US Consumer Staples ETF (IYK) was up 0.8%. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) lost 0.64%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was inactive.Tesla (TSLA) shares were down 3.2% pre-bell after Future Fund Managing Director Gary Black Gary Black on X called the Cybercab event "largely a bust" because of its limited deployment details and the lack of a livestream.The autonomous cab service also came under investigation by the US National Highway Traffic Safety Administration over the process used to claim compliance with federal vehicle safety standards.Winners and Losers:TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) gained 0.7%, the iShares US Technology ETF (IYW) was roughly 0.5% higher, and the iShares Expanded Tech Sector ETF (IGM) was up 0.02%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) rose by more than 1.3%, while the iShares Semiconductor ETF (SOXX) rose by 1.9%.Nvidia (NVDA) shares were up almost 1% in premarket activity after the company said its RTX platform is gaining new tools to simplify local AI agent deployment and also increased its equity investments to $99 billion, CNBC reported Friday.The company is also reportedly expected to invest billions of dollars in AI developer Thinking Machines Lab, The Information reported Thursday, citing the firm's existing investor, Andreessen Horowitz.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) dropped 0.2%, the Vanguard Health Care Index Fund (VHT) was down 1.2%, while the iShares US Healthcare ETF (IYH) slipped 0.2%. The iShares Biotechnology ETF (IBB) gained 0.03%.Novo Nordisk (NVO) stock was down 2.2% premarket after the company said its charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300-square-meter quantum chip production facility in Copenhagen.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) was down 0.4%. Direxion Daily Financial Bull 3X Shares (FAS) was up nearly 1%, while its counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was over 1.1% higher.Robinhood Markets (HOOD) shares traded down 3.7% in early-hours activity after AMC Entertainment (AMC) CEO Adam Aron criticized Robinhood Markets (HOOD) on the recently launched tokenized version of AMC shares, referring to the practice as "contemptible" and "outrageous".IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced almost 0.1%, while the Vanguard Industrials Index Fund (VIS) and the iShares US Industrials ETF (IYJ) were inactive.GE Vernova (GEV) stock was up 0.6% before the opening bell after the company reported a deal with the Venezuelan government that is expected to help stabilize the country's power grid within a year by adding 1 gigawatt of new power, several media outlets reported Thursday, citing US Energy Secretary Chris Wright.EnergyThe iShares US Energy ETF (IYE) retreated by around 0.1%, while the State Street Energy Select Sector SPDR ETF (XLE) was down by 0.6%.NextEra Energy (NEE) stock was down 0.4% before the market open after Dominion Energy (D) and NextEra said shareholders have given consent to proceed with a planned merger between the companies, according to regulatory filings Thursday.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 0.7% to $90.93 per barrel on the New York Mercantile Exchange. Natural gas was up 0.3% to $2.92 per 1 million British Thermal Units. The United States Oil Fund (USO) decreased by 1%, while the United States Natural Gas Fund (UNG) was 1.1% higher.Gold futures for November retreated by 0.5% to $4,515.20 an ounce on the Comex. Silver futures lost 0.3% to $67.49 an ounce. SPDR Gold Shares (GLD) was down by almost 0.1%, and the iShares Silver Trust (SLV) dropped by 0.04%.

Dow JonesNasdaq CompositeS&P 500$AMC$BETH$BITO$D$EEM$EETH$EXI$FAS$FAZ$GEV$GLD$HOOD$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NEE$NVDA$NVO$PMR$QQQ$RTH$SLV$SOXX$SPY$TSLA$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD

Sector Update: Healthcare Stocks Mixed Pre-Bell Friday

Healthcare stocks were mixed pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) 0.1% higher.Novo Nordisk's (NVO) charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Shares of Novo Nordisk were down more than 2% premarket.Bristol Myers Squibb (BMY) told regulators, researchers and patient groups in early June that it had paused trials of its CAR-T treatment zola-cel in autoimmune disorders over potentially life-threatening side effects, The Wall Street Journal reported. Bristol Myers Squibb stock was down 1% pre-bell.Ionis Pharmaceuticals (IONS) shares were 0.8% higher after the company said the US Food and Drug Administration approved zanvastrotm, or zilganersen, to treat Alexander disease in pediatric and adult patients.

$BMY$IBB$IONS$NVO$XLV

Sector Update: Healthcare

Healthcare stocks were declining pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3% and the iShares Biotechnology ETF (IBB) 0.2% lower.Novo Nordisk's (NVO) charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Shares of Novo Nordisk were down more than 1% premarket.

$BCYC$BDRX$BHP$EQNR$ERIC$EVAX$IHG$ING$MREO$NOK$NVO$OPRA$PSO$SQNS$TRIB$WPP

Asia Markets11d ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.50% to 1,960.43 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and semiconductor company Sequans Communications (SQNS), which rose 4% and 3.6% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and lender ING Group (ING), which were up 3.5% and 2.9% respectively.The decliners from continental Europe were led by internet browser company Opera (OPRA) and petroleum refiner Equinor (EQNR), which dropped 2.3% and 1.5% respectively. They were followed by telecommunications companies Nokia (NOK) and Ericsson (ERIC), which lost 0.8% and 0.7% respectively.The gainers from the UK were led by hospitality company InterContinental Hotels Group (IHG) and biopharmaceutical company Bicycle Therapeutics (BCYC), which advanced 4.1% and 3.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and mining company BHP Group (BHP), which increased 1.5% and 1.4% respectively.The decliners from the UK and Ireland were led by educational publisher Pearson (PSO) and biotech firm Trinity Biotech (TRIB), which fell 2.8% and 2.5% respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company Mereo BioPharma Group (MREO), which were down 2.4% and 2.3% respectively.

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks fell late Thursday afternoon, with the NYSE Healthcare Index down 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1%.The iShares Biotechnology ETF (IBB) was down 0.1%.In corporate news, Moderna (MRNA) shares dropped 5% after the firm said it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.HealthEquity (HQY) shares fell past 10% after the company posted fiscal Q2 results.Novo Nordisk (NVO) said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Shares were down 2%.NeoGenomics (NEO) shares jumped past 7% after the company said its RaDaR ST molecular residual disease assay received expanded Medicare coverage to include immunotherapy response monitoring for patients with late-stage solid tumors.

$HQY$MRNA$NEO$NVO

$AKTX$AUTL$BDRX$BNTX$CLLS$DAVA$GSK$MTLS$NCNA$NVO$PSO$SAP$SNY$SQNS$TRIB$UL

Sector Update: Healthcare Stocks Softer in Afternoon Trading

Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.7%.The iShares Biotechnology ETF (IBB) was fractionally lower.In corporate news, Moderna (MRNA) shares fell 4.5% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.HealthEquity (HQY) shares fell past 11% after the company posted fiscal Q2 results.Novo Nordisk (NVO) said Thursday that China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Reuters said the regulator's acceptance of the application is not approval to sell Novo Nordisk's once-daily semaglutide tablets to patients in China, but rather that officials have determined that the application is complete and may enter formal review. Novo shares were down 2.1%.

$HQY$MRNA$NVO

Asia Markets17d ago

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.58% to 1,962.65 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and software firm, SAP (SAP), which rose 4.6% and 3% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which were up 2.9% and 2.1% respectively.The decliners from continental Europe were led by pharmaceutical companies Novo Nordisk (NVO) and Sanofi (SNY), which lost 2.8% and 1.3% respectively. They were followed by biotech firm BioNTech (BNTX) and consumer goods company Unilever (UL), which dropped 1.2% and 1.1% respectively.The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which advanced 5.1% and 4.1% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and educational publisher Pearson (PSO), which increased 1.1% and 0.9% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which fell 6.9% and 3% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and pharmaceutical company GSK (GSK), which were down 2.6% and 1.9% respectively.

Sector Update: Healthcare Stocks Decline Pre-Bell Thursday

Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.6% lower and the iShares Biotechnology ETF (IBB) down 0.5%.Novo Nordisk (NVO) said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.Moderna (MRNA) shares were down nearly 5% amid the company's plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.HealthEquity (HQY) stock was down more than 5% even after the company reported higher fiscal Q2 adjusted earnings and revenue.

$HQY$IBB$MRNA$NVO$XLV

Sector Update: Healthcare

Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.7% lower and the iShares Biotechnology ETF (IBB) down 0.5%.Novo Nordisk (NVO) said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.